Global Flu (Influenza) Vaccine Supply, Demand and Key Producers, 2024-2030

Page: 135

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Flu (Influenza) Vaccine market size is expected to reach $ 7836.7 million by 2030, rising at a market growth of 4.7% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

This report studies the global Flu (Influenza) Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Flu (Influenza) Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Flu (Influenza) Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Flu (Influenza) Vaccine total production and demand, 2019-2030, (K Units)
Global Flu (Influenza) Vaccine total production value, 2019-2030, (USD Million)
Global Flu (Influenza) Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Flu (Influenza) Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Flu (Influenza) Vaccine domestic production, consumption, key domestic manufacturers and share
Global Flu (Influenza) Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Flu (Influenza) Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Flu (Influenza) Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Flu (Influenza) Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hualan Bio, CCBIO, Aleph Biomedical, SANOFI, Adimmune, ZYAK, SINOVAC, Changsheng Biological and SIOBP, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Flu (Influenza) Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Flu (Influenza) Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Flu (Influenza) Vaccine Market, Segmentation by Type
    Split Influenza Vaccine
    Pandemic Influenza Vaccine
    Subunit Influenza Vaccine
    Quadrivalent Influenza Vaccine

Global Flu (Influenza) Vaccine Market, Segmentation by Application
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

Companies Profiled:
    Hualan Bio
    CCBIO
    Aleph Biomedical
    SANOFI
    Adimmune
    ZYAK
    SINOVAC
    Changsheng Biological
    SIOBP
    GSK
    Aimei Hissen
    Tianyuan Bio-pharma(Novartis)
    Simcere Vaxtec

Key Questions Answered
1. How big is the global Flu (Influenza) Vaccine market?
2. What is the demand of the global Flu (Influenza) Vaccine market?
3. What is the year over year growth of the global Flu (Influenza) Vaccine market?
4. What is the production and production value of the global Flu (Influenza) Vaccine market?
5. Who are the key producers in the global Flu (Influenza) Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Flu (Influenza) Vaccine Introduction
    1.2 World Flu (Influenza) Vaccine Supply & Forecast
        1.2.1 World Flu (Influenza) Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Flu (Influenza) Vaccine Production (2019-2030)
        1.2.3 World Flu (Influenza) Vaccine Pricing Trends (2019-2030)
    1.3 World Flu (Influenza) Vaccine Production by Region (Based on Production Site)
        1.3.1 World Flu (Influenza) Vaccine Production Value by Region (2019-2030)
        1.3.2 World Flu (Influenza) Vaccine Production by Region (2019-2030)
        1.3.3 World Flu (Influenza) Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Flu (Influenza) Vaccine Production (2019-2030)
        1.3.5 Europe Flu (Influenza) Vaccine Production (2019-2030)
        1.3.6 China Flu (Influenza) Vaccine Production (2019-2030)
        1.3.7 Japan Flu (Influenza) Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Flu (Influenza) Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Flu (Influenza) Vaccine Major Market Trends

2 Demand Summary
    2.1 World Flu (Influenza) Vaccine Demand (2019-2030)
    2.2 World Flu (Influenza) Vaccine Consumption by Region
        2.2.1 World Flu (Influenza) Vaccine Consumption by Region (2019-2024)
        2.2.2 World Flu (Influenza) Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Flu (Influenza) Vaccine Consumption (2019-2030)
    2.4 China Flu (Influenza) Vaccine Consumption (2019-2030)
    2.5 Europe Flu (Influenza) Vaccine Consumption (2019-2030)
    2.6 Japan Flu (Influenza) Vaccine Consumption (2019-2030)
    2.7 South Korea Flu (Influenza) Vaccine Consumption (2019-2030)
    2.8 ASEAN Flu (Influenza) Vaccine Consumption (2019-2030)
    2.9 India Flu (Influenza) Vaccine Consumption (2019-2030)

3 World Flu (Influenza) Vaccine Manufacturers Competitive Analysis
    3.1 World Flu (Influenza) Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Flu (Influenza) Vaccine Production by Manufacturer (2019-2024)
    3.3 World Flu (Influenza) Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Flu (Influenza) Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Flu (Influenza) Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Flu (Influenza) Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Flu (Influenza) Vaccine in 2023
    3.6 Flu (Influenza) Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Flu (Influenza) Vaccine Market: Region Footprint
        3.6.2 Flu (Influenza) Vaccine Market: Company Product Type Footprint
        3.6.3 Flu (Influenza) Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Flu (Influenza) Vaccine Production Value Comparison
        4.1.1 United States VS China: Flu (Influenza) Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Flu (Influenza) Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Flu (Influenza) Vaccine Production Comparison
        4.2.1 United States VS China: Flu (Influenza) Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Flu (Influenza) Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Flu (Influenza) Vaccine Consumption Comparison
        4.3.1 United States VS China: Flu (Influenza) Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Flu (Influenza) Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Flu (Influenza) Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Flu (Influenza) Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Flu (Influenza) Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Flu (Influenza) Vaccine Production (2019-2024)
    4.5 China Based Flu (Influenza) Vaccine Manufacturers and Market Share
        4.5.1 China Based Flu (Influenza) Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Flu (Influenza) Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Flu (Influenza) Vaccine Production (2019-2024)
    4.6 Rest of World Based Flu (Influenza) Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Flu (Influenza) Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Flu (Influenza) Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Flu (Influenza) Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Flu (Influenza) Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Split Influenza Vaccine
        5.2.2 Pandemic Influenza Vaccine
        5.2.3 Subunit Influenza Vaccine
        5.2.4 Quadrivalent Influenza Vaccine
    5.3 Market Segment by Type
        5.3.1 World Flu (Influenza) Vaccine Production by Type (2019-2030)
        5.3.2 World Flu (Influenza) Vaccine Production Value by Type (2019-2030)
        5.3.3 World Flu (Influenza) Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Flu (Influenza) Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 For Children (6 months to 3 years)
        6.2.2 For Adults and Children over 3 years
    6.3 Market Segment by Application
        6.3.1 World Flu (Influenza) Vaccine Production by Application (2019-2030)
        6.3.2 World Flu (Influenza) Vaccine Production Value by Application (2019-2030)
        6.3.3 World Flu (Influenza) Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Hualan Bio
        7.1.1 Hualan Bio Details
        7.1.2 Hualan Bio Major Business
        7.1.3 Hualan Bio Flu (Influenza) Vaccine Product and Services
        7.1.4 Hualan Bio Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Hualan Bio Recent Developments/Updates
        7.1.6 Hualan Bio Competitive Strengths & Weaknesses
    7.2 CCBIO
        7.2.1 CCBIO Details
        7.2.2 CCBIO Major Business
        7.2.3 CCBIO Flu (Influenza) Vaccine Product and Services
        7.2.4 CCBIO Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 CCBIO Recent Developments/Updates
        7.2.6 CCBIO Competitive Strengths & Weaknesses
    7.3 Aleph Biomedical
        7.3.1 Aleph Biomedical Details
        7.3.2 Aleph Biomedical Major Business
        7.3.3 Aleph Biomedical Flu (Influenza) Vaccine Product and Services
        7.3.4 Aleph Biomedical Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Aleph Biomedical Recent Developments/Updates
        7.3.6 Aleph Biomedical Competitive Strengths & Weaknesses
    7.4 SANOFI
        7.4.1 SANOFI Details
        7.4.2 SANOFI Major Business
        7.4.3 SANOFI Flu (Influenza) Vaccine Product and Services
        7.4.4 SANOFI Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 SANOFI Recent Developments/Updates
        7.4.6 SANOFI Competitive Strengths & Weaknesses
    7.5 Adimmune
        7.5.1 Adimmune Details
        7.5.2 Adimmune Major Business
        7.5.3 Adimmune Flu (Influenza) Vaccine Product and Services
        7.5.4 Adimmune Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Adimmune Recent Developments/Updates
        7.5.6 Adimmune Competitive Strengths & Weaknesses
    7.6 ZYAK
        7.6.1 ZYAK Details
        7.6.2 ZYAK Major Business
        7.6.3 ZYAK Flu (Influenza) Vaccine Product and Services
        7.6.4 ZYAK Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 ZYAK Recent Developments/Updates
        7.6.6 ZYAK Competitive Strengths & Weaknesses
    7.7 SINOVAC
        7.7.1 SINOVAC Details
        7.7.2 SINOVAC Major Business
        7.7.3 SINOVAC Flu (Influenza) Vaccine Product and Services
        7.7.4 SINOVAC Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 SINOVAC Recent Developments/Updates
        7.7.6 SINOVAC Competitive Strengths & Weaknesses
    7.8 Changsheng Biological
        7.8.1 Changsheng Biological Details
        7.8.2 Changsheng Biological Major Business
        7.8.3 Changsheng Biological Flu (Influenza) Vaccine Product and Services
        7.8.4 Changsheng Biological Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Changsheng Biological Recent Developments/Updates
        7.8.6 Changsheng Biological Competitive Strengths & Weaknesses
    7.9 SIOBP
        7.9.1 SIOBP Details
        7.9.2 SIOBP Major Business
        7.9.3 SIOBP Flu (Influenza) Vaccine Product and Services
        7.9.4 SIOBP Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 SIOBP Recent Developments/Updates
        7.9.6 SIOBP Competitive Strengths & Weaknesses
    7.10 GSK
        7.10.1 GSK Details
        7.10.2 GSK Major Business
        7.10.3 GSK Flu (Influenza) Vaccine Product and Services
        7.10.4 GSK Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 GSK Recent Developments/Updates
        7.10.6 GSK Competitive Strengths & Weaknesses
    7.11 Aimei Hissen
        7.11.1 Aimei Hissen Details
        7.11.2 Aimei Hissen Major Business
        7.11.3 Aimei Hissen Flu (Influenza) Vaccine Product and Services
        7.11.4 Aimei Hissen Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Aimei Hissen Recent Developments/Updates
        7.11.6 Aimei Hissen Competitive Strengths & Weaknesses
    7.12 Tianyuan Bio-pharma(Novartis)
        7.12.1 Tianyuan Bio-pharma(Novartis) Details
        7.12.2 Tianyuan Bio-pharma(Novartis) Major Business
        7.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product and Services
        7.12.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Tianyuan Bio-pharma(Novartis) Recent Developments/Updates
        7.12.6 Tianyuan Bio-pharma(Novartis) Competitive Strengths & Weaknesses
    7.13 Simcere Vaxtec
        7.13.1 Simcere Vaxtec Details
        7.13.2 Simcere Vaxtec Major Business
        7.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Product and Services
        7.13.4 Simcere Vaxtec Flu (Influenza) Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Simcere Vaxtec Recent Developments/Updates
        7.13.6 Simcere Vaxtec Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Flu (Influenza) Vaccine Industry Chain
    8.2 Flu (Influenza) Vaccine Upstream Analysis
        8.2.1 Flu (Influenza) Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Flu (Influenza) Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Flu (Influenza) Vaccine Production Mode
    8.6 Flu (Influenza) Vaccine Procurement Model
    8.7 Flu (Influenza) Vaccine Industry Sales Model and Sales Channels
        8.7.1 Flu (Influenza) Vaccine Sales Model
        8.7.2 Flu (Influenza) Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Flu (Influenza) Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Flu (Influenza) Vaccine Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Flu (Influenza) Vaccine Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Flu (Influenza) Vaccine Production Value Market Share by Region (2019-2024)
    Table 5. World Flu (Influenza) Vaccine Production Value Market Share by Region (2025-2030)
    Table 6. World Flu (Influenza) Vaccine Production by Region (2019-2024) & (K Units)
    Table 7. World Flu (Influenza) Vaccine Production by Region (2025-2030) & (K Units)
    Table 8. World Flu (Influenza) Vaccine Production Market Share by Region (2019-2024)
    Table 9. World Flu (Influenza) Vaccine Production Market Share by Region (2025-2030)
    Table 10. World Flu (Influenza) Vaccine Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Flu (Influenza) Vaccine Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Flu (Influenza) Vaccine Major Market Trends
    Table 13. World Flu (Influenza) Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Flu (Influenza) Vaccine Consumption by Region (2019-2024) & (K Units)
    Table 15. World Flu (Influenza) Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Flu (Influenza) Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Flu (Influenza) Vaccine Producers in 2023
    Table 18. World Flu (Influenza) Vaccine Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Flu (Influenza) Vaccine Producers in 2023
    Table 20. World Flu (Influenza) Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Flu (Influenza) Vaccine Company Evaluation Quadrant
    Table 22. World Flu (Influenza) Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Flu (Influenza) Vaccine Production Site of Key Manufacturer
    Table 24. Flu (Influenza) Vaccine Market: Company Product Type Footprint
    Table 25. Flu (Influenza) Vaccine Market: Company Product Application Footprint
    Table 26. Flu (Influenza) Vaccine Competitive Factors
    Table 27. Flu (Influenza) Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Flu (Influenza) Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Flu (Influenza) Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Flu (Influenza) Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Flu (Influenza) Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Flu (Influenza) Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Flu (Influenza) Vaccine Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Flu (Influenza) Vaccine Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Flu (Influenza) Vaccine Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Flu (Influenza) Vaccine Production Market Share (2019-2024)
    Table 37. China Based Flu (Influenza) Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Flu (Influenza) Vaccine Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Flu (Influenza) Vaccine Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Flu (Influenza) Vaccine Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Flu (Influenza) Vaccine Production Market Share (2019-2024)
    Table 42. Rest of World Based Flu (Influenza) Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Flu (Influenza) Vaccine Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Flu (Influenza) Vaccine Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Flu (Influenza) Vaccine Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Flu (Influenza) Vaccine Production Market Share (2019-2024)
    Table 47. World Flu (Influenza) Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Flu (Influenza) Vaccine Production by Type (2019-2024) & (K Units)
    Table 49. World Flu (Influenza) Vaccine Production by Type (2025-2030) & (K Units)
    Table 50. World Flu (Influenza) Vaccine Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Flu (Influenza) Vaccine Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Flu (Influenza) Vaccine Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Flu (Influenza) Vaccine Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Flu (Influenza) Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Flu (Influenza) Vaccine Production by Application (2019-2024) & (K Units)
    Table 56. World Flu (Influenza) Vaccine Production by Application (2025-2030) & (K Units)
    Table 57. World Flu (Influenza) Vaccine Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Flu (Influenza) Vaccine Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Flu (Influenza) Vaccine Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Flu (Influenza) Vaccine Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 62. Hualan Bio Major Business
    Table 63. Hualan Bio Flu (Influenza) Vaccine Product and Services
    Table 64. Hualan Bio Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Hualan Bio Recent Developments/Updates
    Table 66. Hualan Bio Competitive Strengths & Weaknesses
    Table 67. CCBIO Basic Information, Manufacturing Base and Competitors
    Table 68. CCBIO Major Business
    Table 69. CCBIO Flu (Influenza) Vaccine Product and Services
    Table 70. CCBIO Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. CCBIO Recent Developments/Updates
    Table 72. CCBIO Competitive Strengths & Weaknesses
    Table 73. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
    Table 74. Aleph Biomedical Major Business
    Table 75. Aleph Biomedical Flu (Influenza) Vaccine Product and Services
    Table 76. Aleph Biomedical Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Aleph Biomedical Recent Developments/Updates
    Table 78. Aleph Biomedical Competitive Strengths & Weaknesses
    Table 79. SANOFI Basic Information, Manufacturing Base and Competitors
    Table 80. SANOFI Major Business
    Table 81. SANOFI Flu (Influenza) Vaccine Product and Services
    Table 82. SANOFI Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. SANOFI Recent Developments/Updates
    Table 84. SANOFI Competitive Strengths & Weaknesses
    Table 85. Adimmune Basic Information, Manufacturing Base and Competitors
    Table 86. Adimmune Major Business
    Table 87. Adimmune Flu (Influenza) Vaccine Product and Services
    Table 88. Adimmune Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Adimmune Recent Developments/Updates
    Table 90. Adimmune Competitive Strengths & Weaknesses
    Table 91. ZYAK Basic Information, Manufacturing Base and Competitors
    Table 92. ZYAK Major Business
    Table 93. ZYAK Flu (Influenza) Vaccine Product and Services
    Table 94. ZYAK Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. ZYAK Recent Developments/Updates
    Table 96. ZYAK Competitive Strengths & Weaknesses
    Table 97. SINOVAC Basic Information, Manufacturing Base and Competitors
    Table 98. SINOVAC Major Business
    Table 99. SINOVAC Flu (Influenza) Vaccine Product and Services
    Table 100. SINOVAC Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. SINOVAC Recent Developments/Updates
    Table 102. SINOVAC Competitive Strengths & Weaknesses
    Table 103. Changsheng Biological Basic Information, Manufacturing Base and Competitors
    Table 104. Changsheng Biological Major Business
    Table 105. Changsheng Biological Flu (Influenza) Vaccine Product and Services
    Table 106. Changsheng Biological Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Changsheng Biological Recent Developments/Updates
    Table 108. Changsheng Biological Competitive Strengths & Weaknesses
    Table 109. SIOBP Basic Information, Manufacturing Base and Competitors
    Table 110. SIOBP Major Business
    Table 111. SIOBP Flu (Influenza) Vaccine Product and Services
    Table 112. SIOBP Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. SIOBP Recent Developments/Updates
    Table 114. SIOBP Competitive Strengths & Weaknesses
    Table 115. GSK Basic Information, Manufacturing Base and Competitors
    Table 116. GSK Major Business
    Table 117. GSK Flu (Influenza) Vaccine Product and Services
    Table 118. GSK Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. GSK Recent Developments/Updates
    Table 120. GSK Competitive Strengths & Weaknesses
    Table 121. Aimei Hissen Basic Information, Manufacturing Base and Competitors
    Table 122. Aimei Hissen Major Business
    Table 123. Aimei Hissen Flu (Influenza) Vaccine Product and Services
    Table 124. Aimei Hissen Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Aimei Hissen Recent Developments/Updates
    Table 126. Aimei Hissen Competitive Strengths & Weaknesses
    Table 127. Tianyuan Bio-pharma(Novartis) Basic Information, Manufacturing Base and Competitors
    Table 128. Tianyuan Bio-pharma(Novartis) Major Business
    Table 129. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product and Services
    Table 130. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 131. Tianyuan Bio-pharma(Novartis) Recent Developments/Updates
    Table 132. Simcere Vaxtec Basic Information, Manufacturing Base and Competitors
    Table 133. Simcere Vaxtec Major Business
    Table 134. Simcere Vaxtec Flu (Influenza) Vaccine Product and Services
    Table 135. Simcere Vaxtec Flu (Influenza) Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 136. Global Key Players of Flu (Influenza) Vaccine Upstream (Raw Materials)
    Table 137. Flu (Influenza) Vaccine Typical Customers
    Table 138. Flu (Influenza) Vaccine Typical Distributors
List of Figure
    Figure 1. Flu (Influenza) Vaccine Picture
    Figure 2. World Flu (Influenza) Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Flu (Influenza) Vaccine Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Flu (Influenza) Vaccine Production (2019-2030) & (K Units)
    Figure 5. World Flu (Influenza) Vaccine Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Flu (Influenza) Vaccine Production Value Market Share by Region (2019-2030)
    Figure 7. World Flu (Influenza) Vaccine Production Market Share by Region (2019-2030)
    Figure 8. North America Flu (Influenza) Vaccine Production (2019-2030) & (K Units)
    Figure 9. Europe Flu (Influenza) Vaccine Production (2019-2030) & (K Units)
    Figure 10. China Flu (Influenza) Vaccine Production (2019-2030) & (K Units)
    Figure 11. Japan Flu (Influenza) Vaccine Production (2019-2030) & (K Units)
    Figure 12. Flu (Influenza) Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Flu (Influenza) Vaccine Consumption (2019-2030) & (K Units)
    Figure 15. World Flu (Influenza) Vaccine Consumption Market Share by Region (2019-2030)
    Figure 16. United States Flu (Influenza) Vaccine Consumption (2019-2030) & (K Units)
    Figure 17. China Flu (Influenza) Vaccine Consumption (2019-2030) & (K Units)
    Figure 18. Europe Flu (Influenza) Vaccine Consumption (2019-2030) & (K Units)
    Figure 19. Japan Flu (Influenza) Vaccine Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Flu (Influenza) Vaccine Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Flu (Influenza) Vaccine Consumption (2019-2030) & (K Units)
    Figure 22. India Flu (Influenza) Vaccine Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Flu (Influenza) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Flu (Influenza) Vaccine Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Flu (Influenza) Vaccine Markets in 2023
    Figure 26. United States VS China: Flu (Influenza) Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Flu (Influenza) Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Flu (Influenza) Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Flu (Influenza) Vaccine Production Market Share 2023
    Figure 30. China Based Manufacturers Flu (Influenza) Vaccine Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Flu (Influenza) Vaccine Production Market Share 2023
    Figure 32. World Flu (Influenza) Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Flu (Influenza) Vaccine Production Value Market Share by Type in 2023
    Figure 34. Split Influenza Vaccine
    Figure 35. Pandemic Influenza Vaccine
    Figure 36. Subunit Influenza Vaccine
    Figure 37. Quadrivalent Influenza Vaccine
    Figure 38. World Flu (Influenza) Vaccine Production Market Share by Type (2019-2030)
    Figure 39. World Flu (Influenza) Vaccine Production Value Market Share by Type (2019-2030)
    Figure 40. World Flu (Influenza) Vaccine Average Price by Type (2019-2030) & (US$/Unit)
    Figure 41. World Flu (Influenza) Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 42. World Flu (Influenza) Vaccine Production Value Market Share by Application in 2023
    Figure 43. For Children (6 months to 3 years)
    Figure 44. For Adults and Children over 3 years
    Figure 45. World Flu (Influenza) Vaccine Production Market Share by Application (2019-2030)
    Figure 46. World Flu (Influenza) Vaccine Production Value Market Share by Application (2019-2030)
    Figure 47. World Flu (Influenza) Vaccine Average Price by Application (2019-2030) & (US$/Unit)
    Figure 48. Flu (Influenza) Vaccine Industry Chain
    Figure 49. Flu (Influenza) Vaccine Procurement Model
    Figure 50. Flu (Influenza) Vaccine Sales Model
    Figure 51. Flu (Influenza) Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Hualan Bio
CCBIO
Aleph Biomedical
SANOFI
Adimmune
ZYAK
SINOVAC
Changsheng Biological
SIOBP
GSK
Aimei Hissen
Tianyuan Bio-pharma(Novartis)
Simcere Vaxtec

Related Reports

Global Flu (Influenza) Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Flu (Influenza) Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 08 Jan 2023

date Pharma & Healthcare

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Flu (Influenza) Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Flu (Influenza) Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Flu (Influenza) Vaccine market size was valued at USD 5664.4 million in 2023 and is forecast to a readjusted size of USD 7836.7 million by 2030 with a CAGR of 4.7% during review period.

Product Tags

Flu (Influenza) Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>